Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Neuropharmacology|October 16, 2015
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsRafael T de Sousa, Marcus V Zanetti, Andre R Brunoni, et al.Expert Opinion on Therapeutic Targets|July 25, 2014
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderRafael T de Sousa, Rodrigo Machado-Vieira, Carlos A Zarate, et al.Arquivos De Neuro-Psiquiatria|December 20, 2012
Formal Thought Disorder and language impairment in schizophreniaMarcia Radanovic, Rafael T de Sousa, L Valiengo, et al.Expert Review of Clinical Pharmacology|October 27, 2016
Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionIoline D Henter, Rafael T de Sousa, Philip W Gold, et al.Journal of Psychiatric Research|December 17, 2013
Oxidative stress in early stage Bipolar Disorder and the association with response to lithiumRafael T de Sousa, Carlos A Zarate, Marcus V Zanetti, et al.The International Journal of Neuropsychopharmacology|December 19, 2014
Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot studyMarcus V Zanetti, Maria C Otaduy, Rafael T de Sousa, et al.Experimental and Therapeutic Medicine|September 5, 2014
Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept studyRodrigo Machado-Vieira, Marcus V Zanetti, Rafael T DE Sousa, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 8, 2014
Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithiumAlexandre A Loch, Marcus V Zanetti, Rafael T de Sousa, et al.Journal of Psychiatric Research|April 29, 2014
Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodesRafael T de Sousa, Marcus V Zanetti, Geraldo F Busatto, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood DisordersRafael T de Sousa, Alexandre A Loch, André F Carvalho, et al.Pageof 3